Inventor
KHIRE UDAY
US18 patents
⚠️ This page may combine multiple inventors who share the name “KHIRE UDAY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER PHARMACEUTICALS CORP
8 patentsUS7329670B1Feb 12, 2008
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
BAYER PHARMACEUTICALS CORP76 citations97
US7235576B1Jun 26, 2007
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
BAYER PHARMACEUTICALS CORP94 citations97
US7351834B1Apr 1, 2008
ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
BAYER PHARMACEUTICALS CORP64 citations96
US6660752B2Dec 9, 2003
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
BAYER PHARMACEUTICALS CORP24 citations92
US7528255B2May 5, 2009
Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors
BAYER PHARMACEUTICALS CORP35 citations91
US7517880B2Apr 14, 2009
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
BAYER PHARMACEUTICALS CORP25 citations90
US7371763B2May 13, 2008
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
BAYER PHARMACEUTICALS CORP17 citations83
US6919371B2Jul 19, 2005
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
BAYER PHARMACEUTICALS CORP2 citations62
BAYER HEALTHCARE LLC
4 patentsUS7625915B2Dec 1, 2009
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
BAYER HEALTHCARE LLC33 citations92
US7928239B2Apr 19, 2011
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
BAYER HEALTHCARE LLC15 citations83
US7648986B2Jan 19, 2010
Substituted thieno[3,2-D]pyrimidines as Rho kinase inhibitors
BAYER HEALTHCARE LLC16 citations82
US7645878B2Jan 12, 2010
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
BAYER HEALTHCARE LLC2 citations59
RIEDL BERND
2 patentsDIXON JULIE A
2 patentsUS8143393B2Mar 27, 2012
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
DIXON JULIE A5 citations59
US8129379B2Mar 6, 2012
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
DIXON JULIE A4 citations59